Autopsy report · NCT05707702

Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia

“The study did not start as a key co-investigator left the institution.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Boston Medical Center

Sponsor type

University, hospital or other

Conditions

Low-grade Oral Dysplasia

Interventions

Probiotic oral lozenges; Standard of care for oral dysplasia

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain
  “Co-Investigator left institution. No data analysis occurred.” (77% match in meaning)
• Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic Acid
  “The Investigator decided not to pursue this study.” (76% match in meaning)
• Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD
  “Principal investigator left the institution and study was never funded” (76% match in meaning)
• A Study of Mitomycin C, Irinotecan, and Cetuximab
  “The study was discontinued due to the death of a co-investigator and a second co-investigator leaving the institution.” (76% match in meaning)
• Vagus Nerve Stimulator for Autism and Other Developmental Disorders
  “Investigator decided to terminate the study - no participant enrolled.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.